Companies: 10,795·Total market cap: $144.5T
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

MLTXNASDAQHealthcare● Active
$18.00
+$0.10(+0.58%)
Market Cap$1.3B
P/E Ratio
52W High$62.75
52W Low$5.95
Overview

MoonLake Immunotherapeutics (MLTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MLTX · as of Feb 25, 2026

Latest filing snapshot

130
+30+30.00%vs prior year

MoonLake Immunotherapeutics (MLTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
130
Change (1Y)
+30
Growth % (1Y)
+30.00%
Revenue / Employee
Net Income / Employee
$-1.75M
Market Cap
$1.3B

MLTX Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-25130+30+30.00%
2025-02-26100+50+100.00%
2024-02-2950+30+150.00%
2023-03-2020+18+900.00%
2022-02-172+0+0.00%
2021-03-312

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
MeiraGTx Holdings plc
MGTX
MeiraGTx Holdings plc
375
#2
Absci Corporation
ABSI
Absci Corporation
156
#3
MoonLake Immunotherapeutics
MLTX
MoonLake ImmunotherapeuticsYOU
130
#4
CytomX Therapeutics, Inc.
CTMX
CytomX Therapeutics, Inc.
119
#5
Erasca, Inc.
ERAS
Erasca, Inc.
103
#6
ArriVent BioPharma, Inc. Common Stock
AVBP
ArriVent BioPharma, Inc. Common Stock
52
#7
MBX Biosciences, Inc. Common Stock
MBX
MBX Biosciences, Inc. Common Stock
43
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MLTX peer comparison

About MLTX employees

MLTX Employees · Headcount

MoonLake Immunotherapeutics (MLTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, MoonLake Immunotherapeutics had 130 full-time employees globally. Full-time employees only. Global consolidated headcount.

MoonLake Immunotherapeutics's workforce increased by 30 (30.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

MLTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), MoonLake Immunotherapeutics had 130 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

MoonLake Immunotherapeutics employee counthow many employees does MoonLake Immunotherapeutics haveMLTX total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25